Fed to focus on pro-growth, pro-job policies – Brainard

Member of the Federal Reserve Board of Governors Lael Brainard (pictured) stated on Thursday the central bank would focus on “sustainable” “pro-growth, pro-job” policies to help the economy recover from the crisis caused by the coronavirus pandemic. “Those are the kinds of priorities that square very well with our overall framework, which is to ensure the economy is at maximum employment in a sustainable way,” she said.

Earlier in the day, Brainard called for reforms to the system that would add “standardized, reliable, and mandatory disclosures” on how companies are preparing to face the impact of climate change. The Federal Reserve’s emerging focus on climate change won’t lessen its focus on achieving maximum employment, Fed Governor Lael Brainard said on Thursday in response to questions about whether a transition away from carbon-based fuel will kill jobs. The Fed will be focused on long-term risks of climate change but also how the transition to a less carbon-dependent economy “might affect our economic growth over the medium to long term,” Brainard said in comments to an Institute of International Finance summit on climate change. “The focus on investments in a sustainable economy that are pro-growth, that are pro-jobs, those are the kinds of priorities that square very well with our overall framework, which is to ensure the economy is at maximum employment in a sustainable way,” she said. Her remarks were focused on the need for financial firms and their supervisors, including at the Fed, to take more explicit account of the risks climate changes poses to industry business plans and portfolios, and to invest in the complex models and data analysis needed to do so.

Pfizer says South African variant could significantly reduce protective antibodies

(Reuters) – A laboratory study suggests that the South African variant of the coronavirus may reduce antibody protection from the Pfizer Inc/BioNTech SE vaccine by two-thirds, and it is not clear if the shot will be effective against the mutation, the companies said on Wednesday. The study found the vaccine was still able to neutralize the virus and there is not yet evidence from trials in people that the variant reduces vaccine protection, the companies said. Still, they are making investments and talking to regulators about developing an updated version of their mRNA vaccine or a booster shot, if needed. For the study, scientists from the companies and the University of Texas Medical Branch (UTMB) developed an engineered virus that contained the same mutations carried on the spike portion of the highly contagious coronavirus variant first discovered in South Africa, known as B.1.351. The spike, used by the virus to enter human cells, is the primary target of many COVID-19 vaccines. Researchers tested the engineered virus against blood taken from people who had been given the vaccine, and found a two- thirds reduction in the level of neutralizing antibodies compared with its effect on the most common version of the virus prevalent in U.S. trials. Their findings were published in the New England Journal of Medicine (NEJM). Because there is no established benchmark yet to determine what level of antibodies are needed to protect against the virus, it is unclear whether that two-thirds reduction will render the vaccine ineffective against the variant spreading around the world. However, UTMB professor and study co-author Pei-Yong Shi said he believes the Pfizer vaccine will likely be protective against the variant. “We don’t know what the minimum neutralizing number is. We don’t have that cutoff line,” he said, adding that he suspects the immune response observed is likely to be significantly above where it needs to be to provide protection. That is because in clinical trials, both the Pfizer/BioNTech vaccine and a similar shot from Moderna Inc conferred some protection after a single dose with an antibody response lower than the reduced levels caused by the South African variant in the laboratory study. Even if the concerning variant significantly reduces effectiveness, the vaccine should still help protect against severe disease and death, he noted. Health experts have said that is the most important factor in keeping stretched healthcare systems from becoming overwhelmed. More work is needed to understand whether the vaccine works against the South African variant, Shi said, including clinical trials and the development of correlates of protection – the benchmarks to determine what antibody levels are protective.Pfizer and BioNTech said they were doing similar lab work to understand whether their vaccine is effective against another variant first found in Brazil. Moderna published a correspondence in NEJM on Wednesday with similar data previously disclosed elsewhere that showed a sixfold drop antibody levels versus the South African variant. Moderna also said the actual efficacy of its vaccine against the South African variant is yet to be determined. The company has previously said it believes the vaccine will work against the variant..

Researchers urge delay in administering Pfizer vaccine’s second dose, cite strong data

(Reuters) – The second dose of Pfizer Inc’s COVID-19 vaccine could be delayed in order to cover all priority groups as the first one is highly protective, two Canada-based researchers said in a letter published in the New England Journal of Medicine. The vaccine had an efficacy of 92.6% after the first dose, Danuta Skowronski and Gaston De Serres said, based on an analysis of the documents submitted by the drugmaker to the U.S. Food and Drug Administration (FDA). These findings were similar to the first-dose efficacy of 92.1% reported for Moderna Inc’s mRNA-1273 vaccine, according to the letter https://www.nejm.org/doi/full/10.1056/NEJMc2036242 on Wednesday. In its response, Pfizer said alternative dosing regimens of the vaccine had not been evaluated yet and that the decision resided with the health authorities. Some countries, grappling with low supplies, are looking at dosing patterns or volumes that differ from how the vaccines were tested in clinical trials. There are differences over the merits of such strategies, with some arguing the urgency of the pandemic requires flexibility, while others oppose abandoning data-driven approaches for the sake of expediency. Skowronski and De Serres cautioned that there may be uncertainty about the duration of protection with a single dose, but said the administration of the second dose a month after the first provided “little added benefit in the short term”. Skowronski works at the British Columbia Centre for Disease Control, while De Serres is from the Institut National de Santé Publique du Québec In Britain, authorities have said that data supported its decision to move to a 12-week dosing schedule for Pfizer’s COVID vaccine. Both Pfizer and partner BioNTech have warned that they had no evidence to prove it. Pfizer’s vaccine is authorized to be taken 21 days apart. The U.S. FDA and the European Medicines agency have stuck by the interval tested in the trials.

UK gives go-ahead to expose volunteers to COVID in medical trial

LONDON (Reuters) – Britain on Wednesday became the first country in the world to allow volunteers to be exposed to the COVID-19 virus to advance medical research into the pandemic. The trial, which will begin within a month, will see up to 90 healthy volunteers aged 18-30 exposed to COVID-19 in a safe and controlled environment to increase understanding of how the virus affects people, the government said. In order to make the trial as safe as possible, the version of the virus that has been circulating in England since March 2020 will be used rather than one of the new variants. The study will initially seek to establish the smallest amount of virus needed to cause infection, it said. Volunteers could then be given vaccine candidates before being exposed to the virus. The volunteers will be compensated for taking part. British Business Secretary Kwasi Kwarteng said the study would help to find the best and most effective vaccines for use over the longer term. “These human challenge studies will take place here in the UK and will help accelerate scientists’ knowledge of how coronavirus affects people and could eventually further the rapid development of vaccines,” he said. .The government’s vaccines task force, Imperial College London, the Royal Free London NHS Foundation Trust and clinical company hVIVO, which has pioneered viral human challenge models, are working on the study.

US government extends foreclosure moratorium

https://youtu.be/zoWlxbGhdiw

The Biden administration announced Tuesday that it would extend the foreclosure moratorium and mortgage forbearance through the end of June. The actions would block home foreclosures and offer delayed mortgage payments until July, as well as offer six months of additional mortgage forbearance for those who enroll on or before June 30. The actions are an extension of an order that was originally enacted under the Trump administration in March of last year. President Joe Biden — as one of 17 orders he signed on his first day in office — initially extended the eviction and foreclosure moratoriums through the end of March. The eviction moratorium remains in effect through March but was not included in the actions announced Tuesday. The departments of Housing and Urban Development, Veterans Affairs and Agriculture will work together to enact the actions, according to the announcement from the White House. Resources for homeowners will be consolidated on the Consumer Financial Protection Bureau’s website. The White House announcement also pushed for quick passage of

Biden’s $1.9 trillion Covid-19 relief package, arguing the bill would provide states with $10 billion to assist homeowners with mortgage and utility costs.

The Biden administration said Tuesday that 2.7 million homeowners are enrolled in the Covid-19 mortgage forbearance program, which remains available to an additional 11 million government-backed mortgages.

Crude oil rises more than 1% on stimulus optimism

https://youtu.be/wEQqbNNrFc4

THe Bros are showing the hunkies how to get stimulus checks…… Its welfare by another name and at the trailer park they are experts at staying high and sucking off the system. We are reducing Americans to a nation of beggars. And as far as the racial bit I hate every ethnic group especially old fat white babby boomers of which I am one. .I can not be called racially prejudiced since i hate all races especially my own. I have no problem with a police state as long as i own the police.

NEW YORK (Reuters) – Oil prices rose about 1% on Monday as optimism around U.S. stimulus plans and some supply concerns boosted futures, but demand worries prompted by coronavirus lockdowns limited gains. Brent crude futures rose 47 cents, 0.9%, to settle at $55.88 a barrel. U.S. West Texas Intermediate crude ended 50 cents, or 1%, higher at $52.77 a barrel. Officials in U.S. President Joe Biden’s administration on a Sunday call with Republican and Democratic lawmakers tried to head off Republican concerns that his $1.9 trillion pandemic relief proposal was too expensive. “Newly inaugurated President Biden seems to be pushing for a quick approval of his proposed $1.9 trillion pandemic relief package, a development interpreted by the market as a clear indication that the new U.S. administration aims to kick-start an economic recovery, which will naturally benefit fuel consumption,” said Bjornar Tonhaugen, Rystad Energy’s head of oil markets. European nations have imposed tough restrictions to halt the spread of the virus, while China reported a rise in new COVID-19 cases, casting a pall over demand prospects in the world’s largest energy consumer.

WHO team doesn’t rule out virus escaping Wuhan lab – official

A World Health Organization (WHO) official investigating the cause of the pandemic has said he “can’t rule out” the possibility that COVID originated from a Wuhan laboratory. Dr David Nabarro, who is conducting the probe into how the virus developed, said the WHO is currently working with Chinese authorities. He told He told Sky News’ Sophy Ridge On Sunday that “everything will be looked at” by the investigators. Asked if he could rule out the theory that the virus escaped from a laboratory in Wuhan, he said: “The thing about theories is you have to have them as a way to set up the reason why things might be occurring in a particular way. “I can’t rule anything out and I know the team on the spot, as well as those they’re talking to in China, they’re not ruling anything out either. “All options are on the table and everything will be looked at.” As part of the investigation, the WHO is scheduled to visit the Wuhan Institute of Virology. Chinese researchers at the institute say they have handled coronaviruses but have previously strongly rejected claims that COVID-19 came from their lab. Former US president Donald Trump said in April last year that he had seen evidence it had come from a laboratory in China. But health experts and intelligence communities have previously said it is more likely that COVID-19 was naturally occuring rather than man-made. Dr Nabarro added the investigation was getting “exemplary co-operation” from Chinese authorities. He continued: “All the sites that WHO people wanted to visit are being visited, there is an openness for all kinds of communication to take place. “But it’s early days, this is detective work. We’re anticipating this will take quite a lot longer.” Elsewhere in the interview, Dr Nabarro added that “the world should be accessing vaccines in an equal way” as he praised the UK for its rollout. “We have some excellent vaccines that can stop people from dying,” he said. “The only way to deal with a global pandemic is to get fair shares across the world now, that’s the right thing to do. “I’m really hopeful that world leaders in the coming weeks will realise that to have a few countries vaccinating a lot of people and poorer countries have very limited vaccines is not really the way to go ahead economically, socially, environmentally and indeed morally.” Nabarro said the UK having 400 million doses of vaccine on order was “totally understandable” but that once all over-50s in the UK have been inoculated it should consider sharing vaccines with poorer countries through the WHO’s Covax scheme. “At the moment politicians believe that their primary duty is to make sure they get vaccines to perhaps everybody in their countries,” he said. “We think citizens can perhaps talk to their politicians and say ‘wait a minute, we’re actually part of the world, we think the first priority is to make sure everybody in the world gets what they need’.” He said 100 countries have signed up to the WHO’s vaccine-sharing Covax scheme, adding they are “ready to receive vaccines” and there is money available to buy doses. He added: “Do we want to be remembered as a world where those who had the cash could afford to vaccinate their whole populations and countries that didn’t have the cash had to cope with a possibly quite dramatically increasing death rate among their health workers? I don’t think so.”

Economic devastation from coronavirus could eventually kill more than virus, report says

The United Nations has predicted that the economic fallout from the worldwide coronavirus outbreak may end up killing more people than the actual disease itself. The virus’ outbreak has decimated the world economy and threatens the lives of millions around the globe who had been emerging from poverty. Economists forecast a global recession that will result in up to 420 million people plunging into extreme poverty, or making less than $2 a day. The U.S. has seen its unemployment levels reach levels not seen since the Great Depression while vulnerable poorer countries consider the virus’ impact on those already impoverished. “I feel like we’re watching a slow-motion train wreck as it moves through the world’s most fragile countries,” Nancy Lindborg, the president of the nonprofit U.S. Institute of Peace, said, according to the paper. The head of the International Labour Organization (ILO) said with lost working hours higher than originally forecast, and equivalent to 495 million full-time jobs globally in the second quarter of the year. The bleak news from ILO Director-General Guy Ryder coincided with an updated mid-year forecast from the UN body. Lower and middle-income countries have suffered most, with an estimated 23.3 per cent drop in working hours – equivalent to 240 million jobs – in the second quarter. Previously, the ILO had suggested a 14 per cent average drop in global working time, equivalent to the loss of 400 million jobs, relative to the fourth quarter of 2019. Workers in developing nations had also seen their income drop more than 15 per cent, ILO Director-General Guy Ryder told journalists in Geneva. “On top of this, these are the places where there are the weakest social protection systems, so there are very few resources or protections for working people to fall back upon”, he said. “If you look at it regionally, the Americas were worst-affected, with losses of 12.1 per cent.” Mr. Ryder highlighted that while the Governments of richer countries had shored up their economies with hundreds of billions of dollars, poorer nations had been unable to do the same. Without such fiscal stimulus, working hours losses would have been 28 per cent between April and June, instead of 17.3 per cent, he insisted. State financial support has led to the emergence of an extremely worrying “fiscal stimulus gap” between wealthy economies and the developing world, amounting to $982 billion, Mr. Ryder warned. “It runs a risk of leading us to post-COVID world with greater inequalities between regions, countries, sectors and social groups,” he said. “It’s a polar opposite to the better world that we want to build back, and it reminds us all, that unless we are all able to overcome and get out of this pandemic, none of us will.” Although the $982 billion global stimulus package was a staggering sum, the ILO Director-General noted that low-income countries needed a fraction of this figure – $45 billion – to support workers in the same way as wealthier nations had done, while lower-middle-income countries required the remaining $937 billion. To protect workers and economies everywhere, Mr. Ryder warned against any premature loosening of support for health measures aimed at combating the pandemic, in view of increasing infection rates in many countries.

China refused to provide WHO team with raw data on early COVID cases, team member says

FILE PHOTO: A logo is pictured outside a building of the WHO in Geneva

By Brenda Goh

SHANGHAI (Reuters) – China refused to give raw data on early COVID-19 cases to a World Health Organization-led team probing the origins of the pandemic, one of the team’s investigators said, potentially complicating efforts to understand how the outbreak began. The team had requested raw patient data on 174 cases that China had identified from the early phase of the outbreak in the city of Wuhan in December 2019, as well as other cases, but were only provided with a summary, said Dominic Dwyer, an Australian infectious diseases expert who is a member of the team. Such raw data is known as “line listings”, he said, and would typically be anonymised but contain details such as what questions were asked of individual patients, their responses and how their responses were analysed. “That’s standard practice for an outbreak investigation,” he told Reuters on Saturday via video call from Sydney, where hed is currently undergoing quarantine. He said that gaining access to the raw data was especially important since only half of the 174 cases had exposure to the Huanan market, the now-shuttered wholesale seafood centre in Wuhan where the virus was initially detected.

‘Ok to feel overwhelmed’: banks tackle burnout inflamed by virus

LONDON (Reuters) – From a burned-out bank boss to call centre workers isolated at home, the financial sector is suffering a surge in mental health issues exacerbated by the COVID-19 pandemic.

Despite the industry’s cut-throat reputation, senior bankers have responded to the extra strain by rolling out additional help and opening up about their own vulnerabilities.

“It’s okay to feel overwhelmed by what life is throwing at me and mine,” wrote Susan Revell, deputy chair of the $41 trillion asset Bank of New York Mellon’s Europe, Middle East and Africa business.

In a handwritten note Revell, along with other BNY colleagues, shared personal experiences with the institution’s 48,500 staff. She juggles work with caring for elderly relatives and other family struck with ill health and redundancy.

“You can’t pour from an empty cup,” Revell told Reuters. “If I’m not in good shape then I can’t support either my family or my colleagues.”

Her note encouraged colleagues from Brazil to Hong Kong to share their own stories and advice. While banks have for several years been paying greater attention to wellbeing, new initiatives from free therapy to online yoga have proliferated during the pandemic – though they are not always reaching junior staff. In England, a major global banking centre, as many as 10 million people will need new or additional mental health support, The Centre for Mental Health charity says. Despite progress, charities and unions say employers must make extra effort to look out for staff. Picking up on signs is hard with homeworking, so banks including Goldman Sachs and Lloyds have staff on the lookout virtually. “We train our mental health first aiders to look out for body language cues,” said Goldman Sachs executive director Beth Robotham, who has spoken publicly about her own past anxiety attacks. “In a virtual environment, lots of the same rules apply, but it’s more difficult – for instance it’s much easier to lose eye contact. But you may notice the person opts out of being on screen and you’re not sure why, or they seem heavily distracted when they weren’t before, or are showing up late.” Recruiters say mental health is now more likely to come up in hiring discussions, but candidates are still rarely open about existing conditions. “Examples from leaders are hugely influential and helpful. However, people who are still en route to proving themselves in their career are hesitant to do the same,” said Sophie Scholes, a partner at headhunter Heidrick & Struggles. “This particularly applies to recruitment processes where candidates are nervous to self-identify and mostly would choose not to.” Among the raft of new initiatives, NatWest has seen 5,500 staff sign up for online therapy courses just six months since launch. Lloyds has signed up 13,000 people to meditation app Headspace, while Monzo offers online yoga and started classes on meditation and managing stress this year. BNY has increased leave for carers and introduced virtual “tea and talk” sessions. “Every business in the world has now got mental health on its boardroom agenda. I never thought it would happen this quickly,” said Poppy Jaman, chief executive of the City Mental Health Alliance. “As we face a global mental health crisis, 2021 must be the year that every business takes action.” The limitations of online support have, however, been exposed during the pandemic. “Banks like other sectors have done what they can to mitigate the impact of loneliness by setting up things like pub quizzes, yoga and meditation,” said Paul Barrett, head of wellbeing at the Bank Workers Charity (BWC). “But I’m not sure they work as well as they might because of ‘Zoom fatigue’. If you’re using a screen all day, do you then want to use it for a coffee morning?”

Trade union Unite recently supported a bank call centre worker who suffered from anxiety and said he was laid off for taking longer than the one minute gap allowed between calls.

Banks contacted by Reuters said mental health challenges should not hold people back in careers and support was accessible 24/7 through employee assistance helplines. One of the most crucial messages is to tell people they can take time off or work flexible hours if struggling, said Emma Mamo, head of workplace wellbeing at mental health charity Mind. “Providing staff with some downtime to rest and recuperate is absolutely vital and can prevent worsening stress, poor mental health, sickness absence, and even falling out of the workplace altogether in the long run,” she said.